CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-17 | Schoen Eric Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-04-17 | Barry Richard President & CEO | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2025-04-17 | Nassif Freda Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-04-17 | Cook Robert Christopher Chief Operating & Legal Office | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-11-29 | Kupiec James William Chief Medical Officer | Sale | −4,000 | $3.87 | $15K | 0 |
| 2024-11-29 | Schoen Eric Chief Financial Officer | Option exercise | +50,000 | $1.18 | $59K | 71,300 |
| 2024-11-29 | Schoen Eric Chief Financial Officer | Sale | −2,000 | $3.82 | $8K | 0 |
| 2024-11-29 | Schoen Eric Chief Financial Officer | Sale | −59,800 | $3.86 | $231K | 11,500 |
| 2024-11-29 | Schoen Eric Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2024-11-18 | Landen Jaren Chief Clinical Dev. Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-11-18 | Nassif Freda Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-10-01 | Barry Richard President & CEO | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2024-09-06 | Schoen Eric Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-09-06 | Cook Robert Christopher SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-09-06 | Kupiec James William Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-05-20 | BARBIER REMI President & CEO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-20 | Schoen Eric Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-05-20 | Cook Robert Christopher SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-05-20 | Kupiec James William Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-05-16 | ROBERTSON SANFORD Director | Gift | −5,000 | 950,851 |
Page 2 of 17 · 324 trades